How to navigate the GLP-1 era.

The American Diabetes Association's Standards of Care is the reference most US clinicians follow, and it now puts GLP-1 medications at the center of treating diabetes with obesity. Here's what the guideline actually recommends — GLP-1s as the preferred obesity medication in type 2 diabetes, realistic weight-loss targets, the "highest dose isn't always the goal" point on dosing — plus the headline 2026 change: for the first time, the ADA cautiously supports GLP-1 therapy for people with type 1 diabetes and obesity, with important safety guardrails.

Ask whether a GLP-1 helps or hurts anxiety and the honest answer is: both happen, and most people stay stable. Steadier blood sugar, quieter food noise, and weight change calm some people; a minority develop new or worse anxiety, and drug-safety databases show a small reporting signal. It is not a treatment for anxiety. Here's the balanced evidence and, more usefully, what to monitor and when to get help.

ADHD and obesity travel together, so a lot of people on a GLP-1 also have ADHD — and many take a stimulant. There are no trials of GLP-1s as an ADHD treatment, and it shouldn't be used as one. But if you have both, three practical things matter: stacking two appetite suppressants safely, the real ADHD–eating overlap, and the adherence hurdle a weekly injection poses for an ADHD brain. Here's the honest picture.

On the same drug at the same dose, one person loses 25% of their body weight and another loses almost nothing. Clinical trials suggest a third or more can reach 20%+ loss — but a large real-world analysis found only about 1 in 8 lost more than 15% in a year, while nearly half lost under 5%, much of it down to adherence and dosing. Here's what separates strong responders from weak ones — early response, drug choice, sex, diabetes, biology — and what to do if you're not one.

The same GLP-1 medication doesn't act quite the same in men and women. On average women lose more weight, get more side effects, and even absorb more of the drug at the same body weight — differences driven partly by estrogen and testosterone. Here's what the research shows about sex differences in weight loss, tolerability, blood sugar, and biology, and what it means for what you should expect.

For women, a GLP-1 raises questions no man has to think about — the biggest being fertility. These medications can make birth control less reliable and restore ovulation you weren't expecting, so \"Ozempic babies\" are a real phenomenon; they're also not safe in pregnancy. Here are the key women's-health angles: contraception and the pregnancy rules, why GLP-1s often help most in PCOS, protecting bone and muscle, and the menopause overlap.